Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Total Debt (2016 - 2020)

Cardiff Oncology (CRDF) has disclosed Total Debt for 7 consecutive years, with $234270.0 as the latest value for Q2 2020.

  • Quarterly Total Debt changed N/A to $234270.0 in Q2 2020 from the year-ago period, while the trailing twelve-month figure was $234270.0 through Jun 2020, changed N/A year-over-year, with the annual reading at $1.3 million for FY2017, 91.95% down from the prior year.
  • Total Debt hit $234270.0 in Q2 2020 for Cardiff Oncology, down from $1.2 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $16.6 million in Q1 2017 to a low of $234270.0 in Q2 2020.
  • Historically, Total Debt has averaged $8.7 million across 4 years, with a median of $8.4 million in 2016.
  • Biggest five-year swings in Total Debt: increased 7.61% in 2016 and later crashed 92.91% in 2018.
  • Year by year, Total Debt stood at $16.5 million in 2016, then crashed by 91.95% to $1.3 million in 2017, then decreased by 11.76% to $1.2 million in 2018, then tumbled by 80.06% to $234270.0 in 2020.
  • Business Quant data shows Total Debt for CRDF at $234270.0 in Q2 2020, $1.2 million in Q1 2018, and $1.3 million in Q4 2017.